<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01862614</url>
  </required_header>
  <id_info>
    <org_study_id>Buffered Articaine</org_study_id>
    <nct_id>NCT01862614</nct_id>
  </id_info>
  <brief_title>Testing the Anesthetic Effectiveness of Buffered Articaine Injected Next to a Lower First Molar.</brief_title>
  <official_title>A Prospective Randomized, Double-blind Study of the Anesthetic Efficacy of Buffered Articaine as a Primary Buccal Infiltration of the Mandibular First Molar.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ohio State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ohio State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Infiltration (injecting next to the tooth) injections are common in dentistry and a number of&#xD;
      studies have shown that articaine anesthetic, when injected next to a lower molar, is more&#xD;
      effective than a local anesthetic injection of lidocaine. However success rates have not been&#xD;
      as high as hoped for. No objective study has addressed the success rate of buffering&#xD;
      articaine in a mandibular primary buccal infiltration of the first molar. Therefore, the&#xD;
      purpose of this prospective, randomized, double-blind, crossover study is to compare the&#xD;
      degree of pulpal anesthesia obtained with a buffered 4% articaine with 1:100,000 epinephrine&#xD;
      solution versus a non-buffered 4% articaine with 1:100,000 epinephrine solution as a primary&#xD;
      infiltration in the mandibular first molar. The investigators will also record the pain of&#xD;
      injection and postoperative pain.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Using a crossover design, 80 adult subjects will receive two injections consisting of a&#xD;
      primary mandibular first molar infiltration of 1.8 mL of non-buffered 4% articaine with&#xD;
      1:100,000 epinephrine, and 1.8 mL of buffered 4% articaine with 1:100,000 in two separate&#xD;
      appointments spaced at least one week apart. With the crossover design, 160 infiltrations&#xD;
      will be given for the first molar and each subject will serve as his or her own control.&#xD;
      Eighty infiltrations will be administered on the mandibular left side and 80 administered on&#xD;
      the mandibular right side. The order of the two injections will be assigned randomly and the&#xD;
      dentist and subject will be blinded about which anesthetic the subject is given. The&#xD;
      anesthetics used in this study are not experimental. An electric pulp tester (EPT) will be&#xD;
      used to test the lower first molar for anesthesia starting 30 seconds after the injection;&#xD;
      and testing every 30 seconds for the first five minutes. After five minutes the EPT will be&#xD;
      used to test the lower first molar every minute and the contralateral control canine every 5&#xD;
      minutes for a grand total of sixty minutes. The pain of injection and postoperative pain will&#xD;
      be recorded in a survey. Patients will report any postoperative pain or discomfort on a&#xD;
      Visual Analog Scale (VAS) for three days following each appointment. The data will be&#xD;
      statistically analyzed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Actual">May 2014</completion_date>
  <primary_completion_date type="Actual">May 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants Achieving Pulpal Anesthesia.</measure>
    <time_frame>60 minutes per injection sequence.</time_frame>
    <description>An electric pulp tester will be used to test the lower jaw teeth (molars, premolars, and incisors) for anesthesia (numbness) in 4-minute time cycles for 60 minutes. Measurements of less than 80 on the EPT is considered not numb (anesthesia failure). Readings of 80 equate to anesthetic success.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Anesthetic Effectiveness</condition>
  <arm_group>
    <arm_group_label>Buffered Articaine at 1st Appointment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects received an infiltration injection of 1.8cc buffered 4% articaine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Articaine at 1st Appointment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects received an infiltration injection of 1.8cc 4% articaine (unbuffered).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Articaine Hydrochloride + Epinephrine</intervention_name>
    <arm_group_label>Articaine at 1st Appointment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Buffered Articaine Hydrochloride + Epinephrine</intervention_name>
    <arm_group_label>Buffered Articaine at 1st Appointment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Between the age of 18-65 years.&#xD;
&#xD;
          -  in good health (ASA classification II or higher).&#xD;
&#xD;
          -  able to provide informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  allergy to articaine.&#xD;
&#xD;
          -  history of significant medical problems (ASA classification of III or worse).&#xD;
&#xD;
          -  diagnosed depression (taking tri-cyclic antidepressant medications to control).&#xD;
&#xD;
          -  have taken central nervous system (CNS) depressants (including alcohol or any&#xD;
             analgesic medications) within the last 48 hours prior to testing.&#xD;
&#xD;
          -  lactating or pregnant.&#xD;
&#xD;
          -  inability to give informed consent.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>The Ohio State University College of Dentistry, Postle Hall</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Kanaa MD, Whitworth JM, Corbett IP, Meechan JG. Articaine and lidocaine mandibular buccal infiltration anesthesia: a prospective randomized double-blind cross-over study. J Endod. 2006 Apr;32(4):296-8. Epub 2006 Feb 17.</citation>
    <PMID>16554198</PMID>
  </reference>
  <reference>
    <citation>Robertson D, Nusstein J, Reader A, Beck M, McCartney M. The anesthetic efficacy of articaine in buccal infiltration of mandibular posterior teeth. J Am Dent Assoc. 2007 Aug;138(8):1104-12.</citation>
    <PMID>17670879</PMID>
  </reference>
  <reference>
    <citation>Corbett IP, Kanaa MD, Whitworth JM, Meechan JG. Articaine infiltration for anesthesia of mandibular first molars. J Endod. 2008 May;34(5):514-8. doi: 10.1016/j.joen.2008.02.042.</citation>
    <PMID>18436027</PMID>
  </reference>
  <reference>
    <citation>Abdulwahab M, Boynes S, Moore P, Seifikar S, Al-Jazzaf A, Alshuraidah A, Zovko J, Close J. The efficacy of six local anesthetic formulations used for posterior mandibular buccal infiltration anesthesia. J Am Dent Assoc. 2009 Aug;140(8):1018-24.</citation>
    <PMID>19654255</PMID>
  </reference>
  <reference>
    <citation>Sinnott CJ, Garfield JM, Thalhammer JG, Strichartz GR. Addition of sodium bicarbonate to lidocaine decreases the duration of peripheral nerve block in the rat. Anesthesiology. 2000 Oct;93(4):1045-52.</citation>
    <PMID>11020760</PMID>
  </reference>
  <reference>
    <citation>Burmeister CH. A practical method for the extemporaneous preparations of a buffered anesthetic solution. J Am Dent Assoc 22:1514, 1935.</citation>
  </reference>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 22, 2013</study_first_submitted>
  <study_first_submitted_qc>May 22, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 24, 2013</study_first_posted>
  <results_first_submitted>September 20, 2017</results_first_submitted>
  <results_first_submitted_qc>November 6, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">December 2, 2020</results_first_posted>
  <last_update_submitted>May 4, 2021</last_update_submitted>
  <last_update_submitted_qc>May 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ohio State University</investigator_affiliation>
    <investigator_full_name>John Nusstein</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Degree of pulpal anesthesia obtained.</keyword>
  <keyword>Primary infiltration in the lower first molar.</keyword>
  <keyword>Buffered local anesthetic.</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Carticaine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>80 subjects will be recruited in this crossover study. Each of the subjects will receive the injection regimens at 2 separate appointments spaced at least 2 weeks apart.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Articaine (First)</title>
          <description>Subjects receiving 1.8cc articaine injection at first appointment.</description>
        </group>
        <group group_id="P2">
          <title>Buffered Articaine (First)</title>
          <description>Subjects receiving injection of 1.8cc buffered articaine at first appointment.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>First Appointment.</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="40">Received articaine injection at first appointment.</participants>
                <participants group_id="P2" count="40">Received buffered articaine at first appointment.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
                <participants group_id="P2" count="40"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>2 Week Washout Period.</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
                <participants group_id="P2" count="40"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
                <participants group_id="P2" count="40"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Second Appointment.</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="40">Received buffered articaine at second appointment.</participants>
                <participants group_id="P2" count="40">Received articaine at second appointment.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
                <participants group_id="P2" count="40"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Articaine</title>
          <description>Subjects receiving articaine injection.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="80"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="80"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25.3" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Achieving Pulpal Anesthesia.</title>
        <description>An electric pulp tester will be used to test the lower jaw teeth (molars, premolars, and incisors) for anesthesia (numbness) in 4-minute time cycles for 60 minutes. Measurements of less than 80 on the EPT is considered not numb (anesthesia failure). Readings of 80 equate to anesthetic success.</description>
        <time_frame>60 minutes per injection sequence.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Articaine</title>
            <description>Subjects receiving articaine injection.</description>
          </group>
          <group group_id="O2">
            <title>Buffered Articaine</title>
            <description>Subjects receiving an injection of 1.8cc buffered articaine.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Achieving Pulpal Anesthesia.</title>
          <description>An electric pulp tester will be used to test the lower jaw teeth (molars, premolars, and incisors) for anesthesia (numbness) in 4-minute time cycles for 60 minutes. Measurements of less than 80 on the EPT is considered not numb (anesthesia failure). Readings of 80 equate to anesthetic success.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="80"/>
                <count group_id="O2" value="80"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52"/>
                    <measurement group_id="O2" value="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Articaine</title>
          <description>Subjects receiving injection of 1.8cc 4% articaine.</description>
        </group>
        <group group_id="E2">
          <title>Buffered Articaine</title>
          <description>Subjects receiving injection of 1.8cc buffered 4% articaine.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="80"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="80"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. John Nusstein, Professor</name_or_title>
      <organization>The Ohio State University College of Dentistry</organization>
      <phone>614-292-3596</phone>
      <email>nusstein.1@osu.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

